TOP GUIDELINES OF AROMASIN

AROMASIN is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast most cancers who may have gained two to a few several years of tamoxifen and so are switched to AROMASIN for completion of a total of five consecutive a long time of adjuvant hormonal therapy [see Clinical Scientific studies (14.1)].Adj